| Product Code: ETC9972877 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Parenteral Packaging Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Parenteral Packaging Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Parenteral Packaging Market - Industry Life Cycle |
3.4 United States (US) Parenteral Packaging Market - Porter's Five Forces |
3.5 United States (US) Parenteral Packaging Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 United States (US) Parenteral Packaging Market Revenues & Volume Share, By Packaging Type, 2021 & 2031F |
3.7 United States (US) Parenteral Packaging Market Revenues & Volume Share, By Order Type, 2021 & 2031F |
3.8 United States (US) Parenteral Packaging Market Revenues & Volume Share, By Dosage Type, 2021 & 2031F |
3.9 United States (US) Parenteral Packaging Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.10 United States (US) Parenteral Packaging Market Revenues & Volume Share, By Therapeutic Areas, 2021 & 2031F |
3.11 United States (US) Parenteral Packaging Market Revenues & Volume Share, By End-User, 2021 & 2031F |
4 United States (US) Parenteral Packaging Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for biologics and biosimilars |
4.2.2 Growing prevalence of chronic diseases requiring parenteral administration |
4.2.3 Technological advancements in parenteral packaging materials and designs |
4.3 Market Restraints |
4.3.1 Stringent regulations regarding packaging materials and sterilization processes |
4.3.2 High initial investment costs associated with implementing advanced packaging solutions |
5 United States (US) Parenteral Packaging Market Trends |
6 United States (US) Parenteral Packaging Market, By Types |
6.1 United States (US) Parenteral Packaging Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Parenteral Packaging Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 United States (US) Parenteral Packaging Market Revenues & Volume, By Ampoules, 2021- 2031F |
6.1.4 United States (US) Parenteral Packaging Market Revenues & Volume, By Pre-Filled Syringes, 2021- 2031F |
6.1.5 United States (US) Parenteral Packaging Market Revenues & Volume, By Vials, 2021- 2031F |
6.1.6 United States (US) Parenteral Packaging Market Revenues & Volume, By Bottles, 2021- 2031F |
6.1.7 United States (US) Parenteral Packaging Market Revenues & Volume, By Cartridges, 2021- 2031F |
6.1.8 United States (US) Parenteral Packaging Market Revenues & Volume, By Bags, 2021- 2031F |
6.1.9 United States (US) Parenteral Packaging Market Revenues & Volume, By Others, 2021- 2031F |
6.1.10 United States (US) Parenteral Packaging Market Revenues & Volume, By Others, 2021- 2031F |
6.2 United States (US) Parenteral Packaging Market, By Packaging Type |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Parenteral Packaging Market Revenues & Volume, By Small Volume Parenteral Packaging, 2021- 2031F |
6.2.3 United States (US) Parenteral Packaging Market Revenues & Volume, By Large Volume Parenteral Packaging, 2021- 2031F |
6.3 United States (US) Parenteral Packaging Market, By Order Type |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Parenteral Packaging Market Revenues & Volume, By Customized Order, 2021- 2031F |
6.3.3 United States (US) Parenteral Packaging Market Revenues & Volume, By Standard Order, 2021- 2031F |
6.4 United States (US) Parenteral Packaging Market, By Dosage Type |
6.4.1 Overview and Analysis |
6.4.2 United States (US) Parenteral Packaging Market Revenues & Volume, By Single Dosage, 2021- 2031F |
6.4.3 United States (US) Parenteral Packaging Market Revenues & Volume, By Multiple Dosage, 2021- 2031F |
6.5 United States (US) Parenteral Packaging Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 United States (US) Parenteral Packaging Market Revenues & Volume, By Direct Sales, 2021- 2031F |
6.5.3 United States (US) Parenteral Packaging Market Revenues & Volume, By Medical Stores/Pharmacies, 2021- 2031F |
6.5.4 United States (US) Parenteral Packaging Market Revenues & Volume, By E-Commerce, 2021- 2031F |
6.5.5 United States (US) Parenteral Packaging Market Revenues & Volume, By Others, 2021- 2031F |
6.6 United States (US) Parenteral Packaging Market, By Therapeutic Areas |
6.6.1 Overview and Analysis |
6.6.2 United States (US) Parenteral Packaging Market Revenues & Volume, By Cardiovascular/Metabolic, 2021- 2031F |
6.6.3 United States (US) Parenteral Packaging Market Revenues & Volume, By Obstetrics/ Gynaecology, 2021- 2031F |
6.6.4 United States (US) Parenteral Packaging Market Revenues & Volume, By Dermatology, 2021- 2031F |
6.6.5 United States (US) Parenteral Packaging Market Revenues & Volume, By Endocrinology & Metabolic Disease, 2021- 2031F |
6.6.6 United States (US) Parenteral Packaging Market Revenues & Volume, By Gastroenterology, 2021- 2031F |
6.6.7 United States (US) Parenteral Packaging Market Revenues & Volume, By Ophthalmology, 2021- 2031F |
6.6.8 United States (US) Parenteral Packaging Market Revenues & Volume, By Rare Diseases, 2021- 2031F |
6.6.9 United States (US) Parenteral Packaging Market Revenues & Volume, By Rare Diseases, 2021- 2031F |
6.7 United States (US) Parenteral Packaging Market, By End-User |
6.7.1 Overview and Analysis |
6.7.2 United States (US) Parenteral Packaging Market Revenues & Volume, By Pharmaceutical Manufacturers, 2021- 2031F |
6.7.3 United States (US) Parenteral Packaging Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.7.4 United States (US) Parenteral Packaging Market Revenues & Volume, By Clinics, 2021- 2031F |
6.7.5 United States (US) Parenteral Packaging Market Revenues & Volume, By Clinics, 2021- 2031F |
6.7.6 United States (US) Parenteral Packaging Market Revenues & Volume, By Ambulatory Services, 2021- 2031F |
6.7.7 United States (US) Parenteral Packaging Market Revenues & Volume, By Contract Research Organization, 2021- 2031F |
7 United States (US) Parenteral Packaging Market Import-Export Trade Statistics |
7.1 United States (US) Parenteral Packaging Market Export to Major Countries |
7.2 United States (US) Parenteral Packaging Market Imports from Major Countries |
8 United States (US) Parenteral Packaging Market Key Performance Indicators |
8.1 Adoption rate of innovative packaging technologies in the parenteral packaging market |
8.2 Number of new product launches in the parenteral packaging segment |
8.3 Rate of regulatory approvals for new packaging materials and designs in the parenteral packaging market |
9 United States (US) Parenteral Packaging Market - Opportunity Assessment |
9.1 United States (US) Parenteral Packaging Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 United States (US) Parenteral Packaging Market Opportunity Assessment, By Packaging Type, 2021 & 2031F |
9.3 United States (US) Parenteral Packaging Market Opportunity Assessment, By Order Type, 2021 & 2031F |
9.4 United States (US) Parenteral Packaging Market Opportunity Assessment, By Dosage Type, 2021 & 2031F |
9.5 United States (US) Parenteral Packaging Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.6 United States (US) Parenteral Packaging Market Opportunity Assessment, By Therapeutic Areas, 2021 & 2031F |
9.7 United States (US) Parenteral Packaging Market Opportunity Assessment, By End-User, 2021 & 2031F |
10 United States (US) Parenteral Packaging Market - Competitive Landscape |
10.1 United States (US) Parenteral Packaging Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Parenteral Packaging Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here